Published in Ophthalmology on April 01, 2003
Treatment strategies in mucous membrane pemphigoid. Ther Clin Risk Manag (2008) 1.20
The efficacy of sirolimus in the treatment of patients with refractory uveitis. Br J Ophthalmol (2005) 1.15
Advances in the diagnosis and immunotherapy for ocular inflammatory disease. Semin Immunopathol (2008) 1.05
High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis. Am J Ophthalmol (2009) 1.02
High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis. J Autoimmun (2008) 1.01
Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol (2007) 0.97
Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease. Graefes Arch Clin Exp Ophthalmol (2010) 0.88
Intravenous daclizumab for recalcitrant ocular inflammatory disease. Graefes Arch Clin Exp Ophthalmol (2009) 0.85
Immunopathogenesis of ocular Behçet's disease. J Immunol Res (2014) 0.83
Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol (2014) 0.81
Immunotherapeutic strategies in autoimmune uveitis. Autoimmun Rev (2014) 0.80
[Mucous membrane pemphigoid with ocular involvement. Part II: therapy]. Ophthalmologe (2008) 0.77
Pharmacotherapy of scleritis: current paradigms and future directions. Expert Opin Pharmacother (2013) 0.77
Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics. Front Pharmacol (2015) 0.76
The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on. Eye (Lond) (2017) 0.75
Mycophenolate mofetil therapy in uveitis: analysis of eight cases in a tertiary ophthalmic care centre in India. Int Ophthalmol (2007) 0.75
Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA (2008) 7.13
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med (2010) 4.95
Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol (2011) 3.63
Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis. Lancet Oncol (2009) 2.87
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ (2009) 2.23
Plasmapheresis for lupus retinal vasculitis. Arch Ophthalmol (2006) 2.13
The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol (2002) 2.10
The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis (2005) 2.02
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol (2005) 2.01
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol (2008) 1.87
Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology (2011) 1.85
Quality of life outcomes in 599 cancer and non-cancer patients with colostomies. J Surg Res (2006) 1.83
Cyclosporine for ocular inflammatory diseases. Ophthalmology (2010) 1.75
Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology (2005) 1.69
Relapsing polychondritis: a clinical review. Semin Arthritis Rheum (2002) 1.68
Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology (2007) 1.66
Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis. Ocul Immunol Inflamm (2010) 1.62
Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol (2010) 1.61
Methotrexate for ocular inflammatory diseases. Ophthalmology (2009) 1.58
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56
Ocular pemphigus. J Am Acad Dermatol (2005) 1.56
Increased risk of high-grade hypertension with bevacizumab in cancer patients: a meta-analysis. Am J Hypertens (2010) 1.50
Revision and psychometric testing of the City of Hope Quality of Life-Ostomy Questionnaire. Qual Life Res (2004) 1.46
Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage. J Virol (2007) 1.44
Azathioprine for ocular inflammatory diseases. Am J Ophthalmol (2009) 1.44
Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol (2009) 1.41
Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology (2007) 1.36
Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol (2004) 1.33
Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. Ophthalmology (2005) 1.33
Increased risk of serious hemorrhage with bevacizumab in cancer patients: a meta-analysis. Oncology (2010) 1.31
Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin (2006) 1.25
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol (2008) 1.23
Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment. Prog Retin Eye Res (2004) 1.20
Multifocal choroiditis and panuveitis: immunomodulatory therapy. Ophthalmology (2002) 1.20
Primary intraocular lymphoma: A review. Semin Ophthalmol (2006) 1.19
Acute posterior multifocal placoid pigment epitheliopathy: outcome and visual prognosis. Retina (2009) 1.19
360 degrees iris-ciliary body B-cell lymphoma masquerading as post-cataract uveitis. Semin Ophthalmol (2004) 1.18
Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate. Arch Ophthalmol (2003) 1.16
Noninvasive identification of human central sulcus: a comparison of gyral morphology, functional MRI, dipole localization, and direct cortical mapping. Neuroimage (2003) 1.16
High-dose methotrexate for intraocular lymphoma. Clin Cancer Res (2003) 1.15
Cyclophosphamide for ocular inflammatory diseases. Ophthalmology (2009) 1.14
Indications and use of palliative surgery-results of Society of Surgical Oncology survey. Ann Surg Oncol (2002) 1.14
Role of collagen-binding heat shock protein 47 and transforming growth factor-beta1 in conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci (2003) 1.14
Glaucoma and uveitis. Surv Ophthalmol (2012) 1.13
Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol (2007) 1.12
Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina (2007) 1.11
Anterior segment optical coherence tomography. Semin Ophthalmol (2010) 1.09
Biologic response modifier therapy for psoriatic ocular inflammatory disease. Ocul Immunol Inflamm (2008) 1.09
Cysteines in the stalk of the nipah virus G glycoprotein are located in a distinct subdomain critical for fusion activation. J Virol (2012) 1.08
Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci (2003) 1.08
Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes. Cancer Res (2002) 1.08
Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. Ophthalmology (2005) 1.08
Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology (2003) 1.07
Scleritis therapy. Ophthalmology (2011) 1.07
Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology (2002) 1.07
Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology (2006) 1.07
Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm (2009) 1.06
Complications in resident-performed phacoemulsification cataract surgery at New Jersey Medical School. Br J Ophthalmol (2007) 1.06
Bilateral uveitis associated with fluoroquinolone therapy. Cutan Ocul Toxicol (2011) 1.05
Vogt-Koyanagi-Harada syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy. Ophthalmic Surg Lasers Imaging (2009) 1.05
Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease. Semin Ophthalmol (2003) 1.04
The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol (2008) 1.04
Risk of hypotony in noninfectious uveitis. Ophthalmology (2012) 1.03
The spectrum of fundus autofluorescence findings in birdshot chorioretinopathy. J Ophthalmol (2010) 1.02
Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol (2013) 1.02
Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm (2004) 1.02
Subconjunctival bevacizumab for corneal neovascularization. Cornea (2008) 1.02
Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol (2007) 1.01
Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmology (2008) 1.01
The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization. Invest Ophthalmol Vis Sci (2003) 1.01
Ocular manifestations and concepts of systemic vasculitides. Surv Ophthalmol (2004) 1.01
Infliximab for the treatment of refractory scleritis. Br J Ophthalmol (2009) 1.01
Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology (2002) 1.00
Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics. Clin Cancer Res (2003) 1.00
Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome. Semin Ophthalmol (2006) 1.00
Normal versus high tension glaucoma: a comparison of functional and structural defects. J Glaucoma (2010) 0.99
Hypopyon in patients with uveitis. Ophthalmology (2009) 0.99
Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies. Ocul Immunol Inflamm (2004) 0.99
Scleral necrosis in a patient with congenital erythropoietic porphyria. Cornea (2011) 0.98
Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol (2007) 0.97
Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology (2012) 0.97
Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg (2006) 0.97
Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol (2011) 0.97
Successful treatment of idiopathic orbital inflammation with mycophenolate mofetil. Am J Ophthalmol (2005) 0.97
Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome. Ophthalmology (2003) 0.96
Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment. Semin Ophthalmol (2009) 0.96
Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy. Ocul Immunol Inflamm (2011) 0.96
Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease. Surv Ophthalmol (2011) 0.96
Chronic postoperative endophthalmitis due to pseudomonas oryzihabitans. Am J Ophthalmol (2002) 0.96
A mechanistic study of tumor-targeted corrole toxicity. Mol Pharm (2011) 0.96
Ocular disease in patients with ANCA-positive vasculitis. J Ocul Biol Dis Infor (2009) 0.95
Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis. J Cataract Refract Surg (2005) 0.94
Discoid lupus erythematosus masquerading as chronic blepharoconjunctivitis. Ophthalmology (2005) 0.93
A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis. J Ocul Pharmacol Ther (2013) 0.93
Multifocal nodular episcleritis and scleritis with undiagnosed Hodgkin's lymphoma. Ophthalmology (2003) 0.93
Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol (2002) 0.93
Solitary myofibroma of the sclera. Cornea (2007) 0.92
Ocular and extracutaneous involvement in pyoderma gangrenosum. Ophthalmology (2002) 0.92